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Abstract
Background: Ligase IV syndrome, a hereditary disease associated with compromised DNA damage response
mechanisms, and Urofacial syndrome, caused by an impairment of neural cell signaling, are both rare genetic
disorders, whose reports in literature are limited. We describe the first case combining both disorders in a specific
phenotype.
Case presentation: We report a case of a 7-year old girl presenting with a complex phenotype characterized by
multiple congenital abnormalities and dysmorphic features, microcephaly, short stature, combined
immunodeficiency and severe vesicoureteral reflux. Whole Genome Sequencing was performed and a novel ligase
IV homozygous missense c.T1312C/p.Y438H mutation was detected, and is believed to be responsible for most of
the clinical features of the child, except vesicoureteral reflux which has not been previously described for ligase IV
deficiency. However, we observed a second rare damaging (nonsense) homozygous mutation (c.C2125T/p.R709X) in
the leucine-rich repeats and immunoglobulin-like domains 2 gene that encodes a protein implicated in neural cell
signaling and oncogenesis. Interestingly, this mutation has recently been reported as pathogenic and causing
urofacial syndrome, typically displaying vesicoureteral reflux. Thus, this second mutation completes the missing
genetic explanation for this intriguing clinical puzzle. We verified that both mutations fit an autosomal recessive
inheritance model due to extensive consanguinity.
Conclusions: We successfully identified a novel ligase IV mutation, causing ligase IV syndrome, and an additional
rare leucine-rich repeats and immunoglobulin-like domains 2 gene nonsense mutation, in the context of multiple
autosomal recessive conditions due to extensive consanguinity. This work demonstrates the utility of Whole
Genome Sequencing data in clinical diagnosis in such cases where the combination of multiple rare phenotypes
results in very intricate clinical pictures. It also reports a novel causative mutation and a clinical phenotype, which
will help in better defining the essential features of both ligase IV and leucine-rich repeats and immunoglobulin-like
domains 2 deficiency syndromes.
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Background
DNA ligase IV (LIG4, OMIM#601837) is located on
chromosome 13.q33-q34 and encodes a polypeptide of
911 amino acids [1]. It is essential for embryonic devel-
opment and its complete deficiency causes early lethality
accompanied by defective lymphogenesis and defective
neurogenesis in knock-out mice [2, 3].
LIG4 is a component of the nonhomologous end-joining
(NHEJ) complex which is the major DNA double-strand
break (DSB) repair mechanism in human cells in response
to ionizing radiation as well as in V(D)J recombination [4].
Along with other genes, such as Artemis, X-Ray Repair
Cross-Complementing Protein 4 (XRCC4), Protein Kinase
DNA activated Catalytic Polypeptide (PRKDC), and NHEJ1,
encoding V(D)J/NHEJ proteins, it has been found to be
deficient in human genetic disorders.
Ligase IV (LIG4) syndrome (OMIM #606593) is an
autosomal recessive disorder of DNA damage repair, with
cellular hypersensitivity to ionizing radiation, caused by
mutations in LIG4. The disease is highly heterogeneous in
terms of clinical presentation, i.e., various degrees of im-
munodeficiency, ranging from no immunodeficiency to
profound Severe Combined Immunodeficiency (SCID)
phenotypes, have been reported so far. Riballo et al. de-
scribed the first patient with a defect in NHEJ in 1999 [5].
This Turkish patient, without overt immunodeficiency,
developed acute T cell lymphoblastic leukemia at age 14
and was recognized as LIG4 deficient because of an over-
response to radiotherapy. After this first leukemia patient,
several other patients have been identified with LIG4 defi-
ciency and lymphoproliferation or lymphoid malignancies:
EBV associated B cell lymphoma in two patients [6, 7] and
acute T cell leukemia in another patient [8]. Two
additional series of patients have been shown to exhibit
developmental delay and microcephaly along with mild
degrees of immunodeficiency [6, 8–10] and SCID, respect-
ively [7, 11–13]. Recently Murray et al. [14] updated these
published 15 cases with an additional report of 10 LIG4
deficient cases from 9 families all sharing a similar
phenotype (extreme growth retardation, microcephaly and
mild immunodeficiency) and genotype (recurrence of
p.R278H mutation in heterozygosity with a second
variable mutation).
LIG4 mutations have been also identified in 2 patients
diagnosed with Dubowitz syndrome (OMIM # 223370),
suggesting that defective DNA repair triggers the devel-
opment of at least a subset of this syndrome, offering a
molecular basis for this poorly understood hereditary
disease [15]. Dubowitz syndrome is an autosomal reces-
sive disorder with a unique set of clinical features,
including microcephaly, growth failure, mild mental re-
tardation, eczema, immunodeficiency, radiosensitivity
with an increased risk of blood dyscrasia and malig-
nancy, and distinct facial features, which clearly overlap
with the phenotypes of other genetic diseases of defect-
ive DNA repair, including LIG4 syndrome [16].
Leucine-rich repeats and immunoglobulin-like
domains 2 gene (LRIG2, OMIM#608869) is located on
chromosome 1p13.2 and encodes a protein of 1065
amino acids implicated in neural cell signaling and onco-
genesis. Recently, Stuart et al. [17] discovered mutations
in LRIG2 to be the cause of a subset of Urofacial syn-
dromes (UFS2; OMIM#615112), an autosomal recessive
disorder characterized by congenital urinary bladder
dysfunction along with an abnormal facial expression
upon smiling, laughing, and crying. Affected individ-
uals usually experience lifelong urinary incontinence,
recurrent urosepsis, vesicoureteral reflux (VUR), and
renal failure. Some UFS2 patients also have severe




A Syrian 7-year old girl was referred to us for suspected
immunodeficiency of unknown etiology in a clinical
context of multiple congenital abnormalities and devel-
opmental delay. She belonged to a family of Palestinian
ethnicity, characterized by a high degree of consanguin-
ity in two consecutive generations; in particular, the par-
ents were first cousins. An 8-year old sister and a 3-year
old brother were healthy; three first cousins, also born
from a consanguineous marriage, died of recurrent,
severe infections before age 2, lacking any diagnosis in
Syria (Fig. 1a).
The girl was born by normal vaginal delivery, after a
spontaneous and uneventful pregnancy; she was full term
and small for gestational age (birth body weight (BW)
2.5 kg, <3rd percentile at the 39th week of gestation). She
required early admission to NICU, on day 2, for respira-
tory distress secondary to infective pneumonia and
feeding problems with poor suckling. Thereafter, she expe-
rienced recurrent infections: lower respiratory infections
with wheezing approximately every 3–4 weeks, suppura-
tive otitis media, sinusitis, and oral candidiasis. At least
three bacterial pneumonia episodes have been radio-
logically documented from 2013 to 2014, during the
permanence of the child in Qatar, and, as a result of the
recurrence of the respiratory infections, the chest MRI
performed in February 2014, showed left lower lobe
collapse and consolidation and chronic mild pleural
effusions. No anatomical abnormalities, potentially predis-
posing recurrent lower respiratory tract infections were
detected. During the previously mentioned time lapse,
chronic sinusitis and recurrent suppurative otitis media
were diagnosed, and Streptococcus pneumoniae and
Haemophilus influenzae were isolated in several ear swabs.
The brain MRI in February 2014 detected bilateral
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otomastoiditis and pansinusitis. Besides the infectious
complications that required broad spectrum antibiotic
treatment, the patient was presenting feeding difficulties
(poor oral food intake and failure to thrive), requiring
nutritional support with enteral feeding through a nasal
gastric tube.
Starting from the age of 4, the child developed 4 episodes
of urosepsis, secondary to severe vesicoureteral reflux (grade
IV-V) and leading to left kidney hypoplasia and scarring, as
documented in the urethrocystography in November 2013
and abdomen MRI in April 2014. She also presented with
primary nocturnal enuresis but not incontinence.
Fig. 1 a. Family pedigree: the proband is highlighted by the arrow; LIG4 and LRIG2 chromatograms are shown for the homozygous proband; (b).
LIG4 protein domains: the Y438H mutation is located in the adenylation domain (modified from Chistiakov [21]); (c). Pictures of the patient
showing generalized hyposomia, facial dysmorphic features, but not inverted smile, and nail dystrophy
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Physical examination showed generalized hyposomia
(BW and stature <3rd percentile for age) and microcephaly
(head circumference < <3rd percentile for age). Accor-
dingly, the radiological bone age was significantly delayed
(3 ½ years at age of 6). The facial features included triangu-
lar face, small and slightly down-slanting eyes, hypotelor-
ism, prominent nose with wide nasal pyramid, low-set and
large ears and wide mouth. Moreover, she presented with
sparse, thin hairs and nail dystrophy (Fig. 1c).
The skeletal survey revealed the presence of eleven
pairs of ribs and bilateral finger/toe clubbing.
The patient had mild developmental delay with learning
difficulties, underdeveloped language skills, and cognitive
impairment, partly due to lack of schooling for the
frequent hospitalizations. There was no history of
developmental regression. Brain MRI showed normal
parenchyma and ventricular system.
As for the lab tests, serial full blood counts from 2013
to 2014 pointed out a condition of persistent neutro-
penia (ranging from 500/mm3 to 1000/mm3), with a
physiologic neutrophil response to acute infections (up
to 2000/mm3), anemia (Hb ranging from 9 to 10 g/dl)
and mild thrombocytopenia (PLT count between 90,000
and 130,000/mm3). Pancytopenia was revealed for the
first time at age of 3, due to the appearance of bruises
and petechial rash (PLT 50,000/mm3, Hb 7 g/dl, leuco-
penia not otherwise specified).
The level of immunoglobulins (Ig) and Ig subclasses
surprisingly revealed only mild hypo-IgG2 and -IgM
(IgG 1050 mg/dl (n.v. 633–1280), IgA 353 mg/dl (n.v.
33–202), IgM 22 mg/dl (n.v. 48–207), IgG1 954 mg/dl
(n.v. 377–1130), IgG2 43.3 mg/dl (n.v. 68–388), IgG3
80.1 mg/dl (n.v. 15–89), IgG4 1.2 mg/dl (n.v. 1.2-169).
Nevertheless, the flow cytometry count of T- and
B-lymphocytes and NK cells, showed a severe B and T
helper lymphopenia, as detailed in Table 1. The patient
had an incomplete but severe block in precursor B cell
differentiation, resulting in extremely low levels of blood
B cells, whereas the less pronounced reduction of T cells
was mainly caused by an increase in the CD8+ T cells,
probably related to chronic infections. These findings
were confirmed in a second test, after recovery from
acute infections; no systemic steroids were being admin-
istered at that time.
Normal karyotype, 46,XX was detected along with
normal plasma amino acids screen and oxidative burst
in both monocytes and neutrophils in response to stimu-
lants, such as phorbol myristate acetate.
In early 2015, the patient left Qatar back to Syria, where
she died of fatal bilateral pneumonia, and her immuno-
logical work-up remained incomplete, i.e. lymphocyte
T-mitogen stimulation and the response to vaccinations
could not be tested.
Materials and methods
The venous blood samples were collected after informed
consent and upon approval by the Joint IRB, WCM-Q &
HMC, Doha, Qatar, protocol n. 13–00065, from six
members of the family: namely, the affected girl, the two
unaffected siblings, the mother and the maternal uncle
and grandmother (father’s sample was not available at
that time).
The DNA extracted from the patient and the family
members was analyzed by Whole Genome Next Gener-
ation Sequencing [Illumina Hiseq 2500, 125 bp paired-
end reads, 30× average coverage]. Sequence alignment
and variant calling were performed utilizing the Illumina
proprietary pipeline. Ingenuity® Variant Analysis software
was utilized to filter low quality (<20), low coverage
(<20) variants and those with allele frequency > 0.001 in
1000Genomes and ESP. Additional file 1: Table S1 de-
scribes the variants across the sequential filtering steps.
The pedigree of this family suggested an autosomal re-
cessive disease and, therefore, the data were mined for
homozygous damaging variants, conforming to auto-
somal recessive inheritance. All reported variants were
validated by Sanger sequencing.
Prediction of functional effects of mutations was done
by SIFT (http://sift.jcvi.org) and PolyPhen-2 (http://
genetics.bwh.harvard.edu/pph2/), the two tools employed
by Ingenuity.
Genetic analysis
Since a conclusive diagnosis was not reached based on
the clinical presentation, we performed Whole Genome
Sequencing (WGS). A novel LIG4 homozygous missense
c.T1312C/p.Y438H mutation was detected and predicted
to be damaging due to a tyrosine to histidine substitu-
tion in the adenylation domain of the enzyme. This do-
main binds ATP and contains many of the active-site
residues (Fig. 1b). The DNA residue (c.T1312) was
found to be conserved by the PhyloP program which
Table 1 Patient’s immunophenotype assessed by flow cytometry:
counts of B-lymphocytes, T lymphocytes with CD4+ helper and
CD8+ cytotoxic subsets, and NK cells
T/B Lymphocytes and NK populations
cells/μL n.v. cells/μL % n.v. %
CD3+ 816 cells/μL 700–4200 89.0 55–78
CD4+ 112 cells/μL 500–2000 10.9 27–53
CD8+ 416 cells/μL 300–1800 40.8 19–34
CD19+ 3 cells/μL 200–1600 0.3 10–31
CD56+ 66 cells/μL 90–900 8.1 4–26
CD3 + CD4-CD8- 37.3
CD4/CD8 ratio 0.26
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compares genomes of 45 vertebrate species, with a
p-value of 1.6 × 10−5.
Patient’s mother and siblings were healthy and hetero-
zygous for this mutation.
We also found a pathogenic mutation in LRIG2, a
homozygous nonsense substitution c.C2125T resulting
in an arg709-to-ter (R709X) substitution, already re-
ported to cause UFS [17].
Both autosomal recessive variants were present in a
homozygous state in the patient and heterozygous state
or absent in the tested family members. They were ab-
sent from all public databases including 1000 Genome
Project, HapMap, Genome India and Genome Iceland
and in 400 ethnically matched control chromosomes.
Due to the sudden departure of the patient prior to
the disclosure of these results, we were not able to per-
form further functional experiments, such as assessing
protein expression level of the mutant LIG4 enzyme,
testing patient’s in vitro sensitivity to radiotherapy, etc.
Conclusions
In our study, WGS unveiled the presence of multiple
autosomal recessive conditions due to extensive consan-
guinity, in a young patient presenting a complex pheno-
type characterized by microcephaly, growth failure,
immunodeficiency, dysmorphic features, skeletal abnor-
malities, cognitive delay, feeding difficulties and severe
VUR, arising from the co-existence of two rare genetic
diseases, LIG4 syndrome and UFS.
Our patient carried a previously unknown homozy-
gous mutation (c.T1312C/p.Y438H) in the LIG4 gene.
The glutamine to arginine substitution on both alleles
affects the catalytic domain of the gene, is contiguous to
highly conserved ligase motifs, and is predicted to be
damaging. Interestingly, this mutation maps close to the
K424fs*20 mutation, which was previously reported in a
patient with overt SCID and similar cellular phenotype,
and other clinical features comparable to those described
in our patient (microcephaly, growth retardation and
cytopenia) [7]. Moreover, such phenotype has been un-
expectedly associated with normal levels of Ig, as in our
case. In particular, we detected an incomplete but severe
block in precursor B cell differentiation and reduced
numbers of B cells in peripheral blood along with a re-
duced number of CD4+ T-lymphocytes, which is pre-
sumably the result of a reduced efficiency of DSB repair
affecting the ligation phase of V(D)J recombination,
whose impact has been demonstrated to be different on
various cell populations [7]. The essentially normal levels
of serum Ig in the presence of severe primary B lympho-
penia might indicate that a significant number of Ab-
producing plasma cells could be generated from the few
developing B cells. However, even in the presence of
normal Ig levels, the IgG Ig receptor repertoire diversity
is expected to be severely limited, accounting for aspects
of the immunodeficiency [7]. Altogether, the genetic diag-
nosis of LIG4 deficiency, the history of recurrent infections
and the available data on the patient’s immunological status
pointed to a condition of immunodeficiency, whose degree,
however, cannot be fully ascertained due to the unfortunate
passing of the patient.
A second pathogenic mutation in LRIG2 (c.C2125T/
p.R709X) was also detected, with the severe VUR and
the related recurrent urinary tract infections and
enuresis being the phenotypic counterpart of the UFS.
To date only 5 patients with UFS2 have been reported
(Table 2), and Stuart et al. [17] described this same
p.R709X mutation in a homozygous state in two affected
sisters with both facial and urinary phenotypes from a
consanguineous Turkish family, and in heterozygosity in
the unaffected parents.
The fact that our patient did not display the typical fa-
cial features, i.e., inverted smile giving an appearance of
crying, demonstrates that for this given severe mutation
facial features are not always present. A broad phenotypic
variability has already been reported in families affected by
UFS (OMIM#236730) sustained by mutations in
Heparinase-2 gene (HPSE2), and it has been demonstrated
that some affected individuals have only the facial or urin-
ary tract phenotype [19]. The varied expression might be
accounted for by modifier genes, epigenetics or environ-
mental factors that remain to be identified.
Our findings confirm the hypothesis that many severe
dysfunctional bladder problems might have an occult
neurological background similar to UFS without expressing
the grimace when smiling [20], and that LRIG2 might be
implicated in the biological pathways underpinning the
nonsyndromic VUR, which affects 1% of children and is
commonly familial [17]. Stuart et al. described that, among
23 patients with Hinman-Allen syndrome (“non-neuro-
genic neurogenic bladder”), one case had urinary tract
characteristics identical to those seen in UFS without typ-
ical facial features, and displayed compound heterozygous
missense variants in LRIG2 [17].
In summary, we report in a single case how WGS can
help piece together clinical puzzles, in which multiple
causative mutations contribute to an overall complicated
clinical phenotype. So far, few cases of LIG4 syndrome
have been reported with detailed patients’ phenotypes,
and the variety of these phenotypes is remarkable
(Table 3), although in line with the consequences of
hypomorphic mutations [21].
Our findings open up the possibility that the clinical
heterogeneity of some syndromes, such as LIG4 syn-
drome, could be a result of other homozygous mutations
arising on a consanguineous genetic background. Thus,
we believe that the discovery of additional LIG4 causa-
tive mutations from different families and the correlated
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Table 2 Overview of LRIG2 deficient patients (new and literature)
Patienta Recessive mutations Facial phenotype Urinary tract phenotype Constipation Wilms tumour Ref.
Allele 1 Allele 2
F 1.1 c.1230delA c.1230delA YES YES YES NO −17
F 1.2 c.1230delA c.1230delA YES NO NO NO −17
F 2 c.2088delC c.1980–1981ins371 YES YES YES NO −17
F 3.1 c.2125C > T c.2125C > T YES YES YES YES −17
F3.2 c.2125C > T c.2125C > T YES YES Not known NO −17
NEW c.2125C > T c.2125C > T NO YES NO NO This study
Hinman-Allen syndrome c.1648C > T c.2554A > T NO YES NO NO −17
aNamed as reported in single publications
Table 3 Overview of LIG4 syndrome patients (new and literature)
Patienta Recessive mutations RS Microcephaly ID Cytopenia GR DD Malignancy Other Ref.
Allele 1 Allele 2
180BR p.R278H p.R278H YES NK NO NK NK NO Leukemia −5
3703 p.R814X p.R814X YES YES NK YES YES YES Leukemia −8
X p.M249V p.K524
fs20X
YES YES Mild YES YES YES EBV- BCL −6
2303 p.R580X p.R814X YES YES Mild YES YES NK MDS Hypothiroidism, type 2 DM,
hypogonadism
−9
99P0149 p.G469E p.R814X YES YES Mild YES YES YES NO Atypical bone maturation −9
Case 1 p.delK588 p.delK588 ND YES Mild YES YES NO NO −10









NO Skeletal abnormalities 6/10),
primary ovarian failure (2/10),










YES NO Mild YES NO YES NO −9
P1 p.H282L p.K524
fs20X











YES YES SCID NO YES NO NO −12
P-2 p.Q280R p.K524
fs20X
YES YES SCID NO YES NK NO −12
P2 p.H282L p.K524
fs20X
YES YES SCID NO NO YES NO −7
LIG4-1 p.delQ433 p.delQ433 YES NO SCID YES NO NO NO −11




GR Growth retardation, ID Immunodeficiency, DD Developmental delay, RS Radiosensitivity, NK Not known, ND Not determined, EBV-BCL EBV-associated B-cell
lymphoma, DM Diabetes mellitus
aNamed as reported in the single publications
bNo association with the second mutation paired to p.R814X
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phenotypes help to clarify the phenotype truly caused by
LIG4 deficiency. Likewise, our report could help both in
identifying the essential features of LRIG2 deficiency and
in shedding light into the genetic background of dys-
functional voiding diseases, such as nonsyndromic VUR
and Hinman-Allen syndrome.
Nevertheless, we are aware that the complexity of the
WGS data obtained emphasizes the need of further
research for comprehensive understanding of pathogenic
mutations and concomitant genetic modifiers. Assigning a
causal role for genes in disease states is one of the most
challenging points in human genetic research and solicits a
proactive collaboration between clinicians and researchers.
Finally, these results could have guided the clinical
management of the child, if she had not passed away
due to a fatal lung infection. The presence of a LIG4
mutation, accounting for impaired DNA damage repair
mechanisms and, therefore, a higher incidence of malig-
nancies and sensitivity to ionizing radiation and chemo-
therapy, would have been relevant both for prevention
and early diagnosis of cancer. The family will certainly
benefit from the disclosure of these results, in terms of
prenatal or early diagnosis and treatment for both LIG4
syndrome and UFS.
Additional file
Additional file 1: Table S1. Summary of variants across filtering steps.
(DOCX 25 kb)
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